FDA Medical Device Cybersecurity: Requirements, Guidance, and Compliance Checklist

FDA medical device cybersecurity is now a lifecycle obligation. Under section 524B(b) FD&C Act, you must build security into design, submit specified cybersecurity content premarket, and sustain robust postmarket practices. Use this guidance and checklist to turn those requirements into clear, auditable actions.

Cyber Device Definition

A “cyber device” generally includes software and can connect—directly or indirectly—to the internet or another network, creating exposure to cybersecurity threats. If your device meets these criteria, FDA expects cybersecurity to be addressed as part of safety and effectiveness, not as an add‑on control.

• Identify all connectivity paths (wired, wireless, cloud, service ports) and data flows, including third‑party services.
• Classify assets and safety‑critical functions that could be impacted by a cyber event.
• Define intended use environments and threat assumptions for cybersecurity risk management.
• Catalog software and firmware components that could introduce vulnerabilities.
• Confirm supported update mechanisms and how patients or providers will maintain secure configurations.

Premarket Submission Requirements

Section 524B(b) FD&C Act calls for specific cybersecurity content in relevant premarket submissions. Present a cohesive security-by-design narrative that ties risks to controls, tests, and labeling so reviewers can trace your logic from hazard to verification.

• Security architecture: annotated data flow diagrams, trust boundaries, asset inventories, and defensive layers.
• Cybersecurity risk management: threat modeling, misuse and abuse cases, risk controls, and residual risk rationale.
• Verification and validation evidence: static/dynamic analysis, fuzzing, penetration testing, secure code reviews, and vulnerability scans.
• Software bill of materials SBOM: enumerated components, versions, and suppliers, plus your process to monitor, assess, and remediate disclosed vulnerabilities.
• Update and patching plan: authenticated distribution, cryptographic signing, rollback protections, staged deployment, and documented firmware update protocols.
• Coordinated vulnerability disclosure: intake, triage, remediation, and communication practices you will operate after clearance or approval.
• Access control, authentication, authorization, encryption, logging, and key management strategies.
• Labeling: secure configuration guidance, maintenance expectations, update cadence, and end‑of‑support policies.
• Traceability: bidirectional mapping of requirements to risks, controls, tests, and results.

• Submission checklist: include the security architecture summary, risk management file extracts, SBOM, test reports, update/patch strategy, CVD plan, and cybersecurity labeling.

Postmarket Cybersecurity Management Plan

After marketing authorization, maintain continuous oversight and response. Your plan should enable rapid detection, triage, remediation, and communication without compromising clinical performance or patient safety.

• Monitoring and intake: curated threat intelligence, supplier notices, community reports, and coordinated vulnerability disclosure channels.
• Triage and scoring: severity assessment, exploitability and safety impact analysis, and defined service‑level objectives for fixes.
• Remediation and deployment: hotfixes, minor and major releases, emergency workarounds, and validated firmware update protocols with rollback safety.
• Communication: targeted advisories, usage recommendations, and clear instructions for safe implementation of mitigations.
• Operations: secure logging, anomaly detection, incident response, and forensics processes.
• Governance: metrics for time‑to‑remediate, adoption rates, risk acceptance criteria, and end‑of‑life transition plans.

• Postmarket checklist: define roles, escalation paths, monitoring sources, patch timelines, notification templates, and evidence retention.

Software Bill of Materials Implementation

An effective SBOM underpins both premarket submissions and postmarket vigilance. Treat your software bill of materials SBOM as a living inventory that drives vulnerability awareness, supplier accountability, and rapid remediation.

• Scope and structure: include first‑party code, open‑source libraries, third‑party SDKs, operating systems, and firmware modules across all variants.
• Data elements: component name, version, supplier, dependency relationships, known licenses, and integrity metadata (for example, hashes).
• Processes: generate SBOMs automatically during builds, validate accuracy, and baseline them at release for traceability.
• Vulnerability mapping: continuously correlate SBOM components to advisories; document impact analysis and mitigations.
• Distribution and access: include SBOM content in submissions and share appropriately with stakeholders to support risk decisions.
• Maintenance: update SBOMs for fielded configurations and ensure deprecation and replacement details are captured.

• SBOM checklist: authoritative source of components, automated generation, review gates, vulnerability correlation, and secure storage.

Quality Management System Regulation Alignment

Embed cybersecurity into your Quality Management System QMS so controls are planned, executed, and auditable. Align processes with ISO 13485 compliance expectations while meeting FDA’s quality system requirements.

• Design controls: capture cybersecurity requirements, threat models, and verification plans alongside clinical performance needs.
• Risk management: integrate cybersecurity risk management with overall device risk files and link to residual risk justifications.
• Supplier and purchasing controls: flow down security requirements, SBOM deliverables, and vulnerability notification duties.
• Configuration and document control: uniquely identify software/firmware, keys, and build artifacts; preserve reproducible builds.
• CAPA: trend vulnerabilities and incidents to drive preventive actions, secure coding improvements, and process changes.
• Training and competence: role‑based cybersecurity training for developers, testers, field service, and complaint handlers.
• Internal audits and management review: include cybersecurity KPIs, penetration test outcomes, and patch performance.

• QMS checklist: mapped procedures, records, and metrics that prove cybersecurity is designed, verified, released, and serviced under control.

Change Management Procedures

Every modification that can influence security must pass through disciplined change control. Treat cybersecurity impacts as part of safety and effectiveness, and reassess risks before release.

• Security impact analysis: update threat models and risk files for each proposed change, including third‑party updates.
• Testing: regression, security, and performance testing sized to the change; validate logging and alerts still function.
• Regulatory assessment: determine whether a new submission or supplement is warranted based on security impact.
• Artifacts: refresh SBOM entries, risk assessments, verification evidence, and cybersecurity labeling as needed.
• Deployment: stage rollouts, integrity checks, recovery plans, and rollback protections within firmware update protocols.
• Post‑release monitoring: watch for new issues introduced by the change and confirm mitigations are effective in the field.

• Change control checklist: documented impact analysis, approvals, test results, release notes, and customer communication plan.

Coordinated Vulnerability Disclosure Practices

Coordinated vulnerability disclosure builds trust and speeds remediation. Establish and publicize channels so researchers and customers can report issues, then manage them through triage, fixes, and transparent communication.

• Intake: clear reporting instructions, secure submission options, and acknowledgments with tracking IDs.
• Triage: severity scoring, reproducibility checks, and safety impact assessment that feed your remediation plan.
• Remediation: target timelines, patch prioritization, compensating controls, and validation testing.
• Communication: advisories that explain risk, affected versions, mitigations, and update steps; credit reporters when appropriate.
• Program governance: maintain records, metrics, and periodic reviews; align your CVD process with section 524B(b) FD&C Act expectations.

Bringing these elements together—sound architecture, rigorous cybersecurity risk management, living SBOMs, QMS integration, disciplined change control, and mature coordinated vulnerability disclosure—creates a defensible, repeatable path to FDA medical device cybersecurity compliance.

FAQs.

What are the FDA requirements for medical device cybersecurity?

FDA expects you to address cybersecurity across the lifecycle and, for cyber devices, to include specified content in premarket submissions per section 524B(b) FD&C Act. Provide a cohesive package covering security architecture, cybersecurity risk management, verification evidence, an SBOM, update and patching processes, coordinated vulnerability disclosure, and clear cybersecurity labeling.

How is the Software Bill of Materials used in compliance?

The software bill of materials SBOM documents all software and firmware components so you can correlate known vulnerabilities, assess impact, and act quickly. It supports submissions by proving you know what’s inside your device and underpins postmarket monitoring, triage, and targeted updates when new issues emerge.

What is included in a postmarket cybersecurity management plan?

A plan defines monitoring sources, intake via coordinated vulnerability disclosure, triage and severity scoring, remediation workflows, and communication. It also covers validated firmware update protocols, incident response, metrics for timeliness and adoption, and governance for risk acceptance and end‑of‑life transitions.

How should changes impacting cybersecurity be managed?

Run every change through formal change control inside your Quality Management System QMS. Perform a security impact analysis, update threat models and SBOM entries, re‑verify controls, and decide whether regulatory submission is needed. Release with staged deployment, integrity checks, and rollback, then monitor field performance and update labeling or instructions as required for ISO 13485 compliance.